Invesco Asset Management (India) Private Limited has reported an increase in its aggregate holding of equity shares in Sahajanand Medical Technologies Limited. As of October 23, 2026, Invesco Mutual Fund schemes collectively held 5.0549% of the company’s paid-up share capital. This disclosure, made in compliance with SEBI regulations, details the acquisition of 44,20,453 shares, primarily through open market purchases.
Invesco Mutual Fund Discloses Shareholding Increase
Invesco Asset Management (India) Private Limited, acting as the investment manager for Invesco Mutual Fund, has disclosed a substantial acquisition of shares in Sahajanand Medical Technologies Limited. This action is in accordance with Regulation 29(1) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
Key Shareholding Details
The aggregate holding of certain schemes of Invesco Mutual Fund in Sahajanand Medical Technologies Limited stood at 5.0549% of the company’s paid-up share capital as of the close of business hours on October 23, 2026. This represents an increase in their stake within the target company.
Acquisition Details
The acquisition involved 44,20,453 equity shares, primarily through open market transactions. Prior to this acquisition, Invesco Mutual Fund’s holding was 0.7061%, amounting to 7,17,682 shares. The details of the acquisition and the subsequent holding have been provided in the prescribed format as per regulatory requirements.
The total share capital of Sahajanand Medical Technologies Limited before and after the acquisition remains Rs. 10,16,46,778/-, comprising 10,16,46,778 equity shares of Re. 1/- each.
Disclosure Compliance
This disclosure is made to comply with Regulation 29(1) and 29(3) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The details of the acquisition are appended as Annexure 1 for the company’s and stock exchanges’ information.
Source: BSE
